ISOCIPRALINE isoprenaline hydrochloride 0.2 mg/1 mL injection solution ampoule

Šalis: Australija

kalba: anglų

Šaltinis: Department of Health (Therapeutic Goods Administration)

Veiklioji medžiaga:

isoprenaline hydrochloride, Quantity: 0.2 mg

Prieinama:

Cipla Australia Pty Ltd

Vaisto forma:

Injection, solution

Sudėtis:

Excipient Ingredients: disodium edetate; sodium chloride; sodium citrate dihydrate; citric acid; hydrochloric acid; sodium hydroxide; water for injections

Vartojimo būdas:

Intracardial, Intramuscular, Intravenous Bolus, Intravenous Infusion, Subcutaneous

Vienetai pakuotėje:

25 x 1 mL ampoules

Recepto tipas:

(S4) Prescription Only Medicine

Terapinės indikacijos:

ISOCIPRALINE is indicated: - for mild or transient episodes of heart block that do not require electric shock or pacemaker therapy. - for serious episodes of heart block and Adams-Stokes attacks (except when caused by ventricular tachycardia or fibrillation) (see section 4.3 Contraindications). - for use in cardiac arrest until electric shock or pacemaker therapy, the treatments of choice, are available (see section 4.3 Contraindications). - for brochospasm occurring during anaesthesia. - as an adjunct to fluid and electrolyte replacement therapy and the use of other drugs and procedures in the treatment of hypovolaemic and septic shock, low cardiac output (hypoperfusion) states, congestive heart failure and cariodgenic shock (see section 4.4 Special warnings and precautions for use).

Produkto santrauka:

Visual Identification: Clear colourless to practically colourless solution and no visible particulates; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Autorizacija statusas:

Registered

Leidimo data:

2022-03-24